[FATE] YoY Quarter Result on 31-Dec-2018 [#Q4]

Stock
[FATE] Fate Therapeutics, Inc.
Announcement Date
05-Mar-2019
Financial Year
2018
Quarter
31-Dec-2018 [#Q4]
Profit Trend
QoQ- 4.50%
YoY- -28.25%
Quarter Report
FATE's Result
FATE's Financial Summary
View:
Show?
Quarter Result
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Revenue 17,067 15,896 2,802 1,661 1,027 1,027 1,076 58.44%
PBT -68,621 -53,112 -28,302 -16,027 -12,497 -7,940 -7,446 44.74%
Tax -2,206 -861 691 817 -131 -160 -207 48.29%
NP -68,621 -53,112 -28,302 -16,027 -12,497 -7,940 -7,446 44.74%
Tax Rate - - - - - - - -
Total Cost 85,688 69,008 31,104 17,688 13,524 8,967 8,522 46.86%
Ratio Analysis
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
NP Margin -402.07 -334.12 -1,010.06 -964.90 -1,216.85 -773.13 -692.01 -8.64%
Per Share
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
EPS -0.72 -0.61 -0.37 -0.25 -0.29 -0.21 -0.26 18.48%
EPS Diluted -0.72 -0.61 -0.37 -0.25 -0.29 -0.21 -0.26 18.48%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.